Results 211 to 220 of about 165,965 (304)
Preoperative fasting and GLP-1 receptor agonists: gastric retention without increased aspiration risk. [PDF]
Di Vezza F, Sanvitti M, Bilotta F.
europepmc +1 more source
Liver Organoids: From Disease Modelling to Regenerative Medicine
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang +5 more
wiley +1 more source
Incretins (GLP-1 Receptor Agonists) and Polycystic Ovaries. [PDF]
Piazza MJ.
europepmc +1 more source
ABSTRACT Background Hailey‐Hailey disease (HHD) is a rare autosomal dominant blistering disorder caused by mutations in the ATP2C1 gene, which impair keratinocyte adhesion through disrupted calcium signaling. While traditionally considered a structural defect, recent studies suggest that Th2‐mediated inflammation may exacerbate disease pathology ...
Simonetta I. Gaumond +6 more
wiley +1 more source
GLP-1 Receptor Agonists and Noncardiometabolic Outcomes: An Umbrella Review of Meta-Analyses.
Yang K, Liu C, Guo Q, Li Y.
europepmc +1 more source
GLP-1 receptor agonists and acute diabetes complications in adults with type 1 diabetes. [PDF]
Dai H +8 more
europepmc +1 more source
The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort
Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee +2 more
wiley +1 more source
Interventions for binge eating disorder in adults with type 2 diabetes: A systematic review
Abstract Aims Binge eating disorder frequently co‐occurs with type 2 diabetes, creating a dual burden that may complicate both psychological well‐being and glycaemic management. Evidence on the effectiveness of health interventions in this population is limited.
Pernille Fiil Nybo +4 more
wiley +1 more source
GLP-1 receptor agonists for obesity: eligibility across 99 countries. [PDF]
Yoo SGK +46 more
europepmc +1 more source
Abstract Background Clinical services for adults with early‐onset type 2 diabetes (EOT2D) are in urgent need of improvement. Methods We evaluated a multi‐disciplinary clinic for individuals with EOT2D at high risk (HbA1c >9%/triglyceride >20 mmol/L), providing 2–3 flexibly arranged consultations per individual between March 2024 and September 2025 ...
Jonathan Goldney +14 more
wiley +1 more source

